In this study, after a six- to eight-week washout period, patients with mixed hyperlipidemiaLDL cholesterol between 130 and 220 mg/dL (between 100 and 180 mg/dL for type 2 diabetics) and triglycerides ...
The study was a randomized, placebo-controlled comparison of the effects of daily treatment with fenofibrate 160 mg, ezetimibe-simvastatin 10/20 mg, ezetimibe-simvastatin 10/20 mg plus fenofibrate 160 ...
NEW ORLEANS, November 8, 2004 – Results from a new study showed that coadministration of ZETIA® (ezetimibe) and fenofibrate significantly reduced LDL ("bad") cholesterol (LDL-C), non-high density ...
What is fenofibrate used for? Fenofibrate is commonly used to lower bad cholesterol (LDL-C) and increase good cholesterol (HDL-C) in people with high cholesterol or mixed dyslipidemia (elevated ...
The findings of a pilot study offer hope to patients with primary biliary cirrhosis (PBC) who have an incomplete response to ursodeoxycholic acid (UDCA)—the only FDA-approved treatment for the chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback